Ive seen both in the past, some raises were purely institutional, and some were both institutional and retail, hopefully it is both in this case?
Im guessing they are raising this for Phase 3 trial use...I guess that also means they dont as yet have a bio phrama tie up yet?
Your thoughts?
We will find out in the next day or by Monday.
- Forums
- ASX - By Stock
- PAR
- Ann: Trading Halt
Ann: Trading Halt, page-21
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $81.36M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 131244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25818 | 0.235 |
8 | 99346 | 0.225 |
6 | 64676 | 0.220 |
8 | 190313 | 0.215 |
14 | 559696 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 141103 | 6 |
0.245 | 72877 | 3 |
0.250 | 89857 | 4 |
0.255 | 100000 | 1 |
0.260 | 1333 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online